Kyohei Kaburaki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Life-Threatening Prolonged ICANS Following Tarlatamab Treatment in Extensive-Stage Small Cell Lung Cancer With Brain Metastases: A Case Report.

Life-Threatening Prolonged ICANS Following Tarlatamab Treatment in Extensive-Stage Small Cell Lung Cancer With Brain Metastases: A Case Report.

Journal: Respirology case reports

Published: March 18, 2026

Evaluation of 1.1 mm ultrathin cryobiopsy through a guide sheath for sampling of peripheral pulmonary lesions.

Evaluation of 1.1 mm ultrathin cryobiopsy through a guide sheath for sampling of peripheral pulmonary lesions.

Journal: Journal of thoracic disease

Published: August 20, 2025

A Case of Advanced Non-Small Cell Lung Cancer With Hepatocellular Carcinoma-Like Features Responding to a Combination of Durvalumab, Tremelimumab, Carboplatin, and Nab-Paclitaxel.

A Case of Advanced Non-Small Cell Lung Cancer With Hepatocellular Carcinoma-Like Features Responding to a Combination of Durvalumab, Tremelimumab, Carboplatin, and Nab-Paclitaxel.

Journal: Cureus

Published: February 25, 2025

Spontaneously regressing pulmonary tuberculosis detected by computed tomography in a patient with positive interferon-gamma release assay.

Spontaneously regressing pulmonary tuberculosis detected by computed tomography in a patient with positive interferon-gamma release assay.

Journal: Respirology case reports

Published: November 14, 2024

Spigot in pneumothorax cavity: A rare complication of endobronchial Watanabe spigot.

Spigot in pneumothorax cavity: A rare complication of endobronchial Watanabe spigot.

Journal: Respirology case reports

Published: June 11, 2021

Nivolumab-induced anti-aminoacyl-tRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma.

Nivolumab-induced anti-aminoacyl-tRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma.

Journal: Scandinavian journal of rheumatology

Published: May 29, 2019

Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma.

Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma.

Journal: International journal of oncology

Published: May 13, 2019

New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia.

New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 13, 2018

PD-L1 mRNA expression in EGFR-mutant lung adenocarcinoma.

PD-L1 mRNA expression in EGFR-mutant lung adenocarcinoma.

Journal: Oncology reports

Published: July 03, 2017

Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Journal: Internal medicine (Tokyo, Japan)

Published: June 20, 2017

A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer.

A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer.

Journal: Molecular and clinical oncology

Published: November 01, 2016

Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation.

Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation.

Journal: Cancer genomics & proteomics

Published: August 15, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026